Search Results for "Pfizer Oru Biofind"
Matching Channels
Pfizer is a global pharmaceutical company, the largest in world based on annual sales. In 2009, annual sales were worth $45,448m. Pfizer spend £550m on R&D in the UK alone, and have...
Lymphocyte Immune Globulin Pfizer
What is GENOTROPIN? GENOTROPIN (somatropin [rDNA origin] for injection) is a growth hormone treatment. It is an exact copy of the natural growth hormone that our bodies make. The main difference i...
Matching News
Return to top 50 pharma list Summary Website: Pfizer Headquarters: New York, USA Ticker: PFE (NYSE) SEC: Pfizer Recent deal news: Pfizer deal news at Current Partnering Must read report: Partne...
Pfizer is a top pharmaceutical company based in New York, USA. The company was founded in 1849. Pfizer are committed to applying science and its global resources to improve health and well-being at ev...
Ex-Pfizer researchers bag $27m for ‘not-a-Pfizer-spin-out’
"This is not a Pfizer spin out," insists Dr Mike Yeadon CEO of new biotech company Ziarco, which has licensed inflammatory and allergic therapeutic candidates from Pfizer and secured a $27 million ser...
Pfizer: M&A activity 2005-2013
Pfizer has also announced 27 M&A deals since 2005, with the lead deals being the acquisition of Wyeth, King and Vicuron. Abstracted from: Partnering Deals and Alliances with Pfizer Pfizer is invol...
Pfizer announces Zoetis split-off plan
Pfizer intends to split off its remaining interest in Zoetis through an exchange offer. Zoetis, formerly Pfizer's animal health business, completed its initial public offering (IPO) in February 2013....
News Summary: Pfizer buys rights to OTC Nexium
HEARTBURN HEALER: AstraZeneca has sold fellow drugmaker Pfizer the global rights to market a nonprescription version of heartburn drug Nexium, which has annual sales of nearly $8 billlion, starting in...
Pfizer And Hisun announce launch Of Hisun-Pfizer Pharmaceuticals
Pfizer and Zhejiang Hisun Pharmaceuticals announced the launch of Hisun-Pfizer Pharmaceuticals, a joint venture formed between the two companies to develop, manufacture and commercialize off-patent ph...
Pfizer plans split from Zoetis
Pfizer announced its intention to split off its remaining interest in Zoetis, through an exchange offer. Zoetis, formerly Pfizer’s animal health business, completed its initial public offering (...
Matching PubMed Articles
Reply to: Economic evaluation of second generation pneumococcal conjugate vaccines in Norway.
Causal reasoning on biological networks: interpreting transcriptional changes.
The interpretation of high-throughput datasets has remained one of the central challenges of computational biology over the past decade. Furthermore, as the amount of biological knowledge increases, i...
